Decades from now, when we fully understand the biologic basis for the clinical heterogeneity of prostate cancer, we will think of the current era as the Golden Age of Prostate Nomograms. Driven by the ...
Am J Health Syst Pharm. 2008;65(7):624-630. The results of the time-point comparisons of the concentrations that were calculated from each patient's pharmacokinetic parameters from 6 to 22 hours and ...